These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266. Günther J; Schulte K; Wenzel D; Malinowska B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2010 Jan; 381(1):21-31. PubMed ID: 20012265 [TBL] [Abstract][Full Text] [Related]
23. In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium. Senior J; Marshall K; Sangha R; Baxter GS; Clayton JK Br J Pharmacol; 1991 Mar; 102(3):747-53. PubMed ID: 1285399 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists. Morales-Ramos ÁI; Li YH; Hilfiker M; Mecom JS; Eidam P; Shi D; Tseng PS; Brooks C; Zhang D; Wang N; Jaworski JP; Morrow D; Fries H; Edwards R; Jin J Bioorg Med Chem Lett; 2011 May; 21(10):2806-11. PubMed ID: 21514150 [TBL] [Abstract][Full Text] [Related]
25. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues. Matthews JS; Jones RL Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586 [TBL] [Abstract][Full Text] [Related]
26. TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor. Negishi M; Harazono A; Sugimoto Y; Hazato A; Kurozumi S; Ichikawa A Prostaglandins; 1994 Nov; 48(5):275-83. PubMed ID: 7855308 [TBL] [Abstract][Full Text] [Related]
27. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery. Qian YM; Jones RL; Chan KM; Stock AI; Ho JK Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185 [TBL] [Abstract][Full Text] [Related]
28. Prostaglandin EP receptor subtypes involved in regulating HCO(3)(-) secretion from gastroduodenal mucosa. Takeuchi K; Koyama M; Hayashi S; Aihara E Curr Pharm Des; 2010; 16(10):1241-51. PubMed ID: 20166995 [TBL] [Abstract][Full Text] [Related]
29. Mutual interactions of the presynaptic histamine H3 and prostaglandin EP3 receptors on the noradrenergic terminals in the mouse brain. Schlicker E; Marr I Neuroscience; 1997 Jul; 79(1):247-54. PubMed ID: 9178880 [TBL] [Abstract][Full Text] [Related]
30. The EP3 Agonist Sulprostone Enhances Platelet Adhesion But Not Thrombus Formation Under Flow Conditions. Pasterk L; Philipose S; Eller K; Marsche G; Heinemann A; Schuligoi R Pharmacology; 2015; 96(3-4):137-43. PubMed ID: 26228833 [TBL] [Abstract][Full Text] [Related]
31. Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists. Sugimoto I; Kambe T; Okino T; Obitsu T; Ohta N; Nishiyama T; Kinoshita A; Fujimoto T; Egashira H; Yamane S; Shuto S; Tani K; Maruyama T ACS Med Chem Lett; 2017 Jan; 8(1):107-112. PubMed ID: 28105284 [TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells. Bayston T; Ramessur S; Reise J; Jones KG; Powell JT J Vasc Surg; 2003 Aug; 38(2):354-9. PubMed ID: 12891120 [TBL] [Abstract][Full Text] [Related]
33. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597 [TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. Kimple ME; Keller MP; Rabaglia MR; Pasker RL; Neuman JC; Truchan NA; Brar HK; Attie AD Diabetes; 2013 Jun; 62(6):1904-12. PubMed ID: 23349487 [TBL] [Abstract][Full Text] [Related]
35. Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713. Norel X; de Montpreville V; Brink C Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):101-12. PubMed ID: 15560119 [TBL] [Abstract][Full Text] [Related]
36. E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype. Clarke DL; Giembycz MA; Patel HJ; Belvisi MG Br J Pharmacol; 2004 Feb; 141(4):600-9. PubMed ID: 14744812 [TBL] [Abstract][Full Text] [Related]
37. Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y12 antagonist both in-vitro and ex-vivo in human volunteers. Fox SC; May JA; Johnson A; Hermann D; Strieter D; Hartman D; Heptinstall S Platelets; 2013; 24(5):392-400. PubMed ID: 22866894 [TBL] [Abstract][Full Text] [Related]
38. Expression, function, and regulation of E-type prostaglandin receptors (EP3) in the nonischemic and ischemic pig heart. Hohlfeld T; Zucker TP; Meyer J; Schrör K Circ Res; 1997 Nov; 81(5):765-73. PubMed ID: 9351453 [TBL] [Abstract][Full Text] [Related]
39. Constitutive activity of human prostaglandin E receptor EP3 isoforms. Jin J; Mao GF; Ashby B Br J Pharmacol; 1997 May; 121(2):317-23. PubMed ID: 9154343 [TBL] [Abstract][Full Text] [Related]
40. Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes. Xia Y; Chackalamannil S; Greenlee WJ; Jayne C; Neustadt B; Stamford A; Vaccaro H; Xu XL; Baker H; O'Neill K; Woods M; Hawes B; Kowalski T Bioorg Med Chem Lett; 2011 Jun; 21(11):3290-6. PubMed ID: 21536438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]